The Subsequent Decade (2026) Is Poised To Witness A CAGR Of 70.4% For RNA-based Therapeutics and Vaccines Market - PowerPoint PPT Presentation

About This Presentation
Title:

The Subsequent Decade (2026) Is Poised To Witness A CAGR Of 70.4% For RNA-based Therapeutics and Vaccines Market

Description:

Demonstrating herculean expansion at a colossal CAGR, the global market for RNA based therapeutics and vaccines is likely to reach beyond US$ 632 Mn by 2026 end. – PowerPoint PPT presentation

Number of Views:26

less

Transcript and Presenter's Notes

Title: The Subsequent Decade (2026) Is Poised To Witness A CAGR Of 70.4% For RNA-based Therapeutics and Vaccines Market


1
RNA-based Therapeutics and Vaccines Market
Report Id PMRREP12868 Category Life Science
Healthcare
2
About Persistence Market Research
Customized Research
Persistence Market Research(Persistence Market
Research) is a premier provider of syndicated
research reports, custom research reports, and
consulting services. We deliver a complete
packaged solution, which combines current market
intelligence, statistical anecdotes, technology
inputs, valuable growth insights, aerial view of
the competitive framework, and future market
trends. We provide research services at a global
as well as regional level key regions include
GCC, ASEAN, and BRIC. Our offerings cover a broad
spectrum of industries including Chemicals,
Materials, Energy, Technology, Healthcare, and
Retail. We have a global presence with delivery
centers across India specializing in providing
global research reports and country research
reports. Persistence Market Research is
headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Syndicated Research
Investment Research
Social Media Research
Research Capabilities
Sector Coverage
  • Customized Research
  • Syndicated Research
  • Investment Research
  • Social Media Research

  • Automotive and Transportation
  • Electronics, Semiconductor, and ICT
  • Retail and Consumer Products
  • Industrial Automation and Equipment
  • Chemicals Materials
  • Food and Beverages
  • Services and Utilities
  • Energy, Mining, Oil, and Gas


Subscription Information
For detailed subscription information please
contact Website www.persistencemarketresearch.co
m For sales queries or new topics email us on
sales_at_persistencemarketresearch.com
3
The Subsequent Decade (2026) Is Poised To Witness
A CAGR Of 70.4 For RNA-based Therapeutics and
Vaccines Market
  • Tremendous commercialization has been prominently
    driving the growth of RNA based therapeutics and
    vaccines market worldwide. Persistence Market
    Research projects massive growth prospects for
    the global RNA based therapeutics and vaccines
    market over the seven-year period, 2019-2026.
    Demonstrating herculean expansion at a colossal
    CAGR, the global market for RNA based
    therapeutics and vaccines is likely to reach
    beyond US 632 Mn by 2026 end.
  • As indicated by a recently conducted study by
    PMR, the market for RNA based therapeutics and
    vaccines will gain a major boost from bolstering
    research activities, which are witnessing strong
    governmental as well as private research
    institutional support over the past few years
  • While emergence of and growing research interests
    in RNA based therapeutics and vaccines has
    broadened the scope of therapeutics targeting a
    range of health conditions, market study points
    at a majority of research activities in clinical
    development.

Get Sample Copy of Report _at_ https//www.persistenc
emarketresearch.com/samples/12868
4
Company Profiles
  • Alnylam Pharmaceuticals, Inc.
  • Arbutus Biopharma Corp.
  • Arrowhead Pharmaceuticals, Inc.
  • BioNTech AG
  • CureVac AG
  • Dicerna Pharmaceuticals, Inc.
  • Regulus Therapeutics, Inc.
  • Marina Biotech, Inc.
  • miRagen Therapeutics
  • Moderna Therapeutics, Inc.
  • Quark Pharmaceuticals, Inc.
  • Santaris Pharma A/S (A Roche Company)
  • Sylentis S.A.

Access Full Report _at_ https//www.persistencemarket
research.com/checkout/12868
5
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com